Stocklytics Platform
Asset logo for symbol CELUW
Celularity
CELUW33
$0.01arrow_drop_down8.04%-$0.00
Penny Stock
Asset logo for symbol CELUW
CELUW33

$0.01

arrow_drop_down8.04%

Performance History

Chart placeholder
Key Stats
Open$0.01
Prev. Close$0.01
EPS-0.87
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range0.01
0.01
52 Week Range0.00
0.05
Ratios
Revenue-
EPS-0.87

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Celularity (CELUW)

Celularity Inc. (CELUW) is a biotechnology company specializing in developing and commercializing cellular therapies for cancer and other serious diseases. The company's stock price history shows a steady upward trend over the past year, with occasional dips and peaks. Investors can use this information to assess the company's financial performance and potential for future growth. Currently, CELUW is quoted at $15 per share, but keep in mind that stock prices can fluctuate based on market conditions and investor sentiment.
When analyzing Celularity Inc.'s stock, it's important to consider the latest news and developments surrounding the company. For up-to-date information, it is advised to refer to reliable financial news sources or the company's official announcements. News can have a significant impact on stock prices and may provide insights into Celularity's future plans and prospects.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Robert Joseph Hariri M.D., Ph.D.
Headquarters
Florham Park
Employees
225
Exchange
NASDAQ
add Celularity to watchlist

Keep an eye on Celularity

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the market capitalization of Celularity (CELUW)?

Celularity (CELUW) has a market capitalization of . The average daily trading volume is 943, indicating the stock's liquidity and investor engagement.
help

What is Celularity's (CELUW) price per share?

The current price per share for Celularity (CELUW) is $0.02. The stock has seen a price change of -$0 recently, indicating a -8.04% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Celularity (CELUW)?

For Celularity (CELUW), the 52-week high is $0.06, which is 222.4% from the current price. The 52-week low is $0.01, the current price is 258.82% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Celularity (CELUW) a growth stock?

Celularity (CELUW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Celularity as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Celularity (CELUW) stock price performance year to date (YTD)?

As of the latest data, Celularity (CELUW) has a year-to-date price change of -63.4%. Over the past month, the stock has experienced a price change of -8.5%. Over the last three months, the change has been -3.68%. Over the past six months, the figure is -54.25%.
help

Is Celularity (CELUW) a profitable company?

Celularity (CELUW) has a net income of -$196.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 29.66% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -89.55% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 26.68%, providing insight into the company's sales performance and growth. The gross profit is $6.76M. Operating income is noted at -$76.48M. Furthermore, the EBITDA is -$67.16M.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media